Disposition of single-dose oral enrofloxacin in the horse

Journal of Veterinary Pharmacology and Therapeutics

Volumn 19, Issue 4, 1996, Pages 316-319

  Langston, V C ^a   Sedrish, S ^b   Boothe, D M ^c  

^a MISSISSIPPI STATE UNIVERSITY   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENROFLOXACIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISPOSITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORSE; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VETERINARY MEDICINE;

EID: 0029775897     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2885.1996.tb00057.x     Document Type: Article

References (11)

1. Berg, J. (1988) Clinical indications for enrofloxacin in domestic animals and poultry. In Quinolones: A Symposium: A new class of antimicrobial agents for use in veterinary medicine. pp. 25-34. Veterinary Learning Systems, Lawrenceville, NJ, USA.
2. Copeland, D. (1992) Personal communication. Manager of Clinical Development; Bayer Corporation Agriculture Division. Health Products, Shawnee Mission, KS, USA.
3. Forrest, A., Nix, D.E., Ballow, C.H., Goss, T.F., Birmingham, M.C. & Schentag, J.J. (1993a) Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrobial Agents and Chemotherapy, 37(5), 1073-1081.
4. Forrest, A., Amantea, M., Collins, D.A., Chodosh, S. & Schentag, J.J. (1993b) Pharmacodynamics of oral opc-17116 in patients with acute bacterial exacerbations of chronic bronchitis. Programs and Abstracts: 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, October 17-20: Session 14, Paper 81. p. 134.
5. Gibaldi, M. & Perrier, D. (1982) Pharmacokinetics, 2nd edn. pp. 409-424, 433-457. Marcel Dekker, New York.
6. R (enrofloxacin) beim Hund. Kleintierpraxis. 38, S95-102.
7. Schentag. J. (1991) Correlation of pharmacokinetic parameters to efficacy of antibiotics: relationships between serum concentrations. MIC values, and bacterial eradication in patients with gram-negative pneumonia. Scandinavian Journal of Infectious Disease (Suppl.). 74, 218-234.
8. Sullivan, M., Cooper, B.W., Nightingale, C.H., Quintiliani, R. & Lawlor, M.T. (1993) Evaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection model. Antimicrobial Agents and Chemotherapy, 37(2). 234-239.
9. Tyczkowska, K., Hedeen, K.M., Aucoin, D.P. & Aronson. A.L. (1989) High-performance liquid Chromatographic method for the simultaneous determination of enrofloxacin and its primary metabolite ciprofloxacin in canine serum and prostatic tissue. Journal of Chromatography, 493, 337-346.
10. Vogelman, B., Gudmundsson, G., Leggett, J., Turnidge, J., Ebert, S. & Craig, W. (1988) Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. Journal of Infectious Disease, 158(4), 831-847.
11. Walker, R.D., Stein, G.E., Hauptman, J.G. & MacDonald, K.H. (1992) Pharmacokinetic evaluation of enrofloxacin administered orally to healthy dogs. American Journal of Veterinary Research, 53(12), 2315-2319.